Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Rapastinel (INNTooltip International Nonproprietary Name) (former developmental code name GLYX-13) is a novel antidepressant that was under development by Allergan (previously Naurex) as an adjunctive therapy for the treatment of treatment-resistant depression. It is a centrally active, intravenously administered (non-orally active) amidated tetrapeptide…
History & Research
Explore the main themes, entities and connections around Rapastinel. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
nmda receptor antidepressant development allergan naurex therapy novel glyx-13 drug effects adjunctive selective modulator clinical also name code fda designation
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Rapastinel | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Rapastinel | ATC code | None | 1.00 | infobox |
| Rapastinel | CAS Number | 117928-94-6 Y | 1.00 | infobox |
| Rapastinel | ChemSpider | 25069944 | 1.00 | infobox |
| Rapastinel | CompTox Dashboard (EPA) | DTXSID501030481 | 1.00 | infobox |
| Rapastinel | Drug class | Selective NMDA receptor modulator | 1.00 | infobox |
| Rapastinel | Formula | C18H31N5O6 | 1.00 | infobox |
| Rapastinel | Legal status | US: Investigational New Drug | 1.00 | infobox |
| Rapastinel | Molar mass | 413.475 g·mol−1 | 1.00 | infobox |
| Rapastinel | Other names | GLYX-13; BV-102 | 1.00 | infobox |
| Rapastinel | PubChem CID | 14539800 | 1.00 | infobox |
| Rapastinel | Routes of administration | Intravenous | 1.00 | infobox |
| Rapastinel | UNII | 6A1X56B95E | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.